Literature DB >> 17029726

Abrogation of streptococcal pyrogenic exotoxin B-mediated suppression of phagocytosis in U937 cells by Cordyceps sinensis mycelium via production of cytokines.

Chih-Feng Kuo1, Cheng-Chih Chen, Chiou-Feng Lin, Ming-Shiou Jan, Robert Y Huang, Yueh-Hsia Luo, Woei-Jer Chuang, Chia-Chin Sheu, Yee-Shin Lin.   

Abstract

Streptococcal pyrogenic exotoxin B (SPE B) is a virulent factor in group A streptococcal infection. We previously showed that SPE B reduced phagocytosis in human monocytic U937 cells. Here we show that the mycelium extract of Cordyceps sinensis (CS), a Chinese immunomodulatory herbal medicine, increased phagocytosis in U937 cells. Neither heat nor trypsin pretreatment prevented CS extract from causing this increase. Further studies indicated that SPE B-mediated suppression of U937 cell phagocytic activity was abrogated by CS extract. Factors in the conditioned medium from CS-extract-treated U937 cells were responsible for blocking the SPE B-mediated suppression of phagocytosis. Heating the conditioned medium eliminated the increase, which suggested that the U937-cell protein products augmented phagocytosis. Analyzing cytokine mRNA expression of U937 cells revealed increases in interferon-gamma (IFN-gamma), interleukin (IL)-12 p35 and p40, and tumor necrosis factor-alpha (TNF-alpha), but not in IL-1beta, IL-6, or IL-8. Treating U937 cells with anti-IFN-gamma, IL-12, and TNF-alpha antibodies also eliminated the conditioned medium-induced increase in phagocytosis. Taken together, SPE B inhibited phagocytosis, but CS mycelium extract abrogated this inhibition by causing cytokine production.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17029726     DOI: 10.1016/j.fct.2006.08.017

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  6 in total

1.  Tussah silkmoth pupae improve anti-tumor properties of Cordyceps militaris (L.) Link by increasing the levels of major metabolite cordycepin.

Authors:  Zhixin Wen; Xingfan Du; Nan Meng; Yajie Li; Rui Mi; Xuejun Li; Yongxin Sun; Shuhui Ma; Shuying Li
Journal:  RSC Adv       Date:  2019-02-13       Impact factor: 4.036

Review 2.  The Chemical Constituents and Pharmacological Actions of Cordyceps sinensis.

Authors:  Yi Liu; Jihui Wang; Wei Wang; Hanyue Zhang; Xuelan Zhang; Chunchao Han
Journal:  Evid Based Complement Alternat Med       Date:  2015-04-16       Impact factor: 2.629

Review 3.  A Systematic Review of the Mysterious Caterpillar Fungus Ophiocordyceps sinensis in Dong-ChongXiaCao ( Dōng Chóng Xià Cǎo) and Related Bioactive Ingredients.

Authors:  Hui-Chen Lo; Chienyan Hsieh; Fang-Yi Lin; Tai-Hao Hsu
Journal:  J Tradit Complement Med       Date:  2013-01

4.  HPLC-ICP-MS speciation analysis and risk assessment of arsenic in Cordyceps sinensis.

Authors:  Tian-Tian Zuo; Yao-Lei Li; Hong-Yu Jin; Fei Gao; Qi Wang; Ya-Dan Wang; Shuang-Cheng Ma
Journal:  Chin Med       Date:  2018-04-16       Impact factor: 5.455

Review 5.  Cordyceps: a traditional Chinese medicine and another fungal therapeutic biofactory?

Authors:  R Russell M Paterson
Journal:  Phytochemistry       Date:  2008-03-17       Impact factor: 4.072

6.  The Effect of Natural-Based Formulation (NBF) on the Response of RAW264.7 Macrophages to LPS as an In Vitro Model of Inflammation.

Authors:  Sheelu Monga; Basem Fares; Rami Yashaev; Dov Melamed; Meygal Kahana; Fuad Fares; Abraham Weizman; Moshe Gavish
Journal:  J Fungi (Basel)       Date:  2022-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.